
Hamilton, Ontario, Canada
OmniaBio is a technology-focused cell and gene therapy CDMO. We specialize in providing advanced cell-based processes and gene delivery services for both autologous and allogenic therapies, covering the entire product lifecycle from preclinical development to commercial manufacturing.
- Revenue
- $31.2M
- Customers
- -
- Year founded
- 2022
- Funding
- -
- Team size
- 165
- Growth
- -